IMCoPharma’s regulatory team has recently started the registration process of several APIs in Ukraine. Namely these are Bimatoprost, Latanoprost, Tafluprost and Travoprost, produced by Cayman Pharma, Czech Republic.
These ingredients are intended for the treatment of glaucoma in the form of eye drops in ophthalmology.
Please, feel free to contact us for more information about progress of the registration.